Core Laboratories (CLB) Cash Flow Statement

Click line-items for a historical chart and %

Net income	48.49M
Net (recovery) provision for doubtful accounts
Provisions for inventory obsolescence
Equity in earnings of affiliates
Stock-based compensation	16.76M
Depreciation and amortization	20.32M
Non-cash interest expense
Gain on sale of assets
Gain on insurance recovery
Loss on exchange of Senior Exchangeable Notes
Realization of pension obligation
Increase in value of life insurance policies	-505K
Deferred income taxes	-3.91M
Accounts receivable	37.61M
Inventories	3M
Prepaid expenses and other current assets	4.03M
Other assets	-128K
Accounts payable	-3.02M
Accrued expenses	-13.02M
Other long-term liabilities	1.4M
Net cash provided by operating activities	108.68M
Capital expenditures	-7.74M
Payments to Acquire Intangible Assets	-205K
Business Acquisitions
Proceeds from sale of assets	705K
Proceeds from insurance recovery
Premiums on life insurance	-2.02M
Net cash used in investing activities	-10.5M
Repayment of debt borrowings
Proceeds from Stock Options Exercised
Excess Tax Benefit from Share-based Compensation, Financing Activities	-187K
Payments of Debt Issuance Costs	0
Settlement of Warrants
Non-controlling interest - contributions
Payments of Dividends, Noncontrolling Interest	-211K
Payments of Dividends	-70.88M
Payments for Repurchase of Common Stock	-2.16M
Net cash used in financing activities	-103.46M
NET CHANGE IN CASH AND CASH EQUIVALENTS	-5.28M
CASH AND CASH EQUIVALENTS, beginning of period	22.49M

Entities mentioned with CLb

View All Entities